Engineered Cell-Based Therapeutics: Synthetic Biology Meets Immunology
Author:
Publisher
Frontiers Media SA
Subject
Biomedical Engineering,Histology,Bioengineering,Biotechnology
Reference57 articles.
1. Human epidermal growth factor receptor 2 (HER2) - Specific chimeric antigen receptor - Modified T cells for the immunotherapy of HER2-positive sarcoma;Ahmed;J. Clin. Oncol.,2015
2. Toxicity management for patients receiving novel T-cell engaging therapies;Barrett;Curr. Opin. Pediatr.,2014
3. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies;Beatty;Cancer Immunol. Res.,2018
4. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease;Bluestone;Expert Opin. Ther. Targets,2015
5. Bioactivity and safety of IL13Rα2-redirected chimeric antigen receptor CD8+T cells in patients with recurrent glioblastoma;Brown;Clin. Cancer Res.,2015
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exosome-based nanoparticles and cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10
2. De novo design of allosterically switchable protein assemblies;Nature;2024-08-14
3. Advancing Cancer Immune Cell Therapies via Engineered iPSC-Based Strategies;Interdisciplinary Cancer Research;2024
4. Design and mathematical analysis of activating transcriptional amplifiers that enable modular temporal control in synthetic juxtacrine circuits;Synthetic and Systems Biotechnology;2023-12
5. De novo design of allosterically switchable protein assemblies;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3